Skip to main content
. 2022 Jul 5;12:11380. doi: 10.1038/s41598-022-15778-3

Table 1.

Stomach cancer screening rates for the period 2018–2020.

Characteristics 2018 (n = 3495a) 2019 (n = 3539a) 2020 (n = 3557a) 2019 versus 2018 2020 versus 2019
SR, %b SR, %b SR, %b SE SRR 95% CI SE SRR 95% CI
Overall 32.6 32.7 27.2 0.024 1.00 0.96–1.05 0.024 0.83 0.79–0.87
Age group, years
40–49 33.8 34.3 26.7 0.041 1.01 0.94–1.10 0.043 0.78 0.72–0.85
50–59 32.6 32.7 28.3 0.041 1.00 0.92–1.09 0.042 0.86 0.80–0.94
60–69 32.7 35.5 27.9 0.050 1.09 0.98–1.20 0.049 0.79 0.71–0.86
70–74 27.0 24.4 24.4 0.077 0.91 0.78–1.05 0.065 1.00 0.88–1.14
Sex
Male 33.8 32.4 26.8 0.034 0.96 0.90–1.02 0.034 0.83 0.77–0.88
Female 31.5 33.1 27.6 0.034 1.05 0.98–1.12 0.033 0.83 0.78–0.89
Residential area
Metropolitan 34.8 33.1 23.2 0.036 0.95 0.89–1.02 0.036 0.70 0.65–0.75
Urban 32.1 34.9 30.3 0.036 1.09 1.01–1.17 0.035 0.87 0.81–0.93
Rural 27.0 22.5 30.1 0.070 0.83 0.73–0.95 0.074 1.34 1.16–1.55
Monthly household income ($)
 ≤ 3999 28.9 29.6 27.1 0.040 1.03 0.95–1.11 0.040 0.91 0.85–0.99
4000–6999 34.5 30.9 25.1 0.039 0.90 0.83–0.97 0.040 0.81 0.75–0.88
 ≥ 7000 35.0 39.1 29.4 0.046 1.12 1.02–1.22 0.044 0.75 0.69–0.82
Education status
Middle school or lower 23.1 24.6 26.1 0.062 1.07 0.94–1.20 0.060 1.06 0.94–1.20
High school 34.0 32.1 26.7 0.033 0.95 0.89–1.01 0.033 0.83 0.78–0.89
College or higher 34.5 38.0 28.4 0.042 1.10 1.02–1.20 0.042 0.75 0.69–0.81
Chronic diseasec
No 31.5 33.4 25.7 0.031 1.06 1.00–1.13 0.031 0.77 0.72–0.82
Yes 34.3 31.8 29.1 0.037 0.93 0.86–1.00 0.036 0.91 0.85–0.98

SR screening rate; SRR screening rate ratio; SE standard error; CI confidence interval.

aThe n value is the number of individuals eligible for gastric cancer screening (aged over 40 years); bSRs were defined as the proportion of screened individuals within the last 1 year; Weighting values from the Population and Housing Census were applied to calculate the SRs cChronic disease, individuals who are diagnosed with any of following diseases: hypertension, diabetes, tuberculosis, hepatitis B, hepatitis C, liver cirrhosis, chronic gastritis, stomach/duodenal ulcers, polyps, benign breast diseases, uterine myoma, and hyperlipidemia.